Darmstadt, Germany

Heinz-Hermann Bokel


 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1994-2016

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Heinz-Hermann Bokel: Innovator in Pharmaceutical Patents

Introduction

Heinz-Hermann Bokel is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds and their applications. With a total of seven patents to his name, Bokel's work has had a considerable impact on medical science.

Latest Patents

Bokel's latest patents include the polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt. This invention relates to solvates and crystalline modifications of the compound, as well as processes for manufacturing these modifications. The applications of these inventions are particularly relevant in the treatment and prophylaxis of conditions mediated by the inhibition of signal transduction of kinases, especially tyrosine kinases, which are implicated in diseases such as cancer.

Career Highlights

Throughout his career, Bokel has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His expertise in patent development has positioned him as a key figure in the innovation of therapeutic agents.

Collaborations

Bokel has collaborated with notable colleagues such as Axel Becker and Clemens Kuehn. These partnerships have further enhanced his contributions to the field and have facilitated the advancement of pharmaceutical research.

Conclusion

Heinz-Hermann Bokel's innovative work in the pharmaceutical sector exemplifies the importance of patents in advancing medical science. His contributions continue to influence the development of treatments for critical health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…